Display options
Cite
Finlay JC, Zhu TC, Dimofte A, et al. . Proc SPIE Int Soc Opt Eng. 2005;5689:299-310doi: 10.1117/12.590709.
Finlay, J. C., Zhu, T. C., Dimofte, A., Stripp, D., Malkowicz, S. B., Whittington, R., Miles, J., Glatstein, E., & Hahn, S. M. (2005). . Proceedings of SPIE--the International Society for Optical Engineering, 5689299-310. https://doi.org/10.1117/12.590709
Finlay, Jarod C, et al. "." Proceedings of SPIE--the International Society for Optical Engineering vol. 5689 (2005): 299-310. doi: https://doi.org/10.1117/12.590709
Finlay JC, Zhu TC, Dimofte A, Stripp D, Malkowicz SB, Whittington R, Miles J, Glatstein E, Hahn SM. . Proc SPIE Int Soc Opt Eng. 2005 Apr 22;5689:299-310. doi: 10.1117/12.590709. PMID: 26136613; PMCID: PMC4484877.
Copy Download .nbib Format: NLM
Share it on

Proc SPIE Int Soc Opt Eng. 2005 Apr 22;5689:299-310. doi: 10.1117/12.590709.

[No title available]

Proceedings of SPIE--the International Society for Optical Engineering

Jarod C Finlay, Timothy C Zhu, Andreea Dimofte, Diana Stripp, S Bruce Malkowicz, Richard Whittington, Jeremy Miles, Eli Glatstein, Stephen M Hahn

Affiliations

  1. Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.

PMID: 26136613 PMCID: PMC4484877 DOI: 10.1117/12.590709

Abstract

Among the challenges to the clinical implementation of photodynamic therapy (PDT) is the delivery of a uniform photodynamic dose to induce uniform damage to the target tissue. As the photodynamic dose depends on both the local sensitizer concentration and the local fluence rate of treatment light, knowledge of both of these factors is essential to the delivery of uniform dose. In this paper, we investigate the distribution and kinetics of the photosensitizer motexafin lutetium (MLu, Lutrin®) as revealed by its fluorescence emission. Our current prostate treatment protocol involves interstitial illumination of the organ

References

  1. Appl Opt. 1993 Jul 1;32(19):3585-95 - PubMed
  2. J Photochem Photobiol B. 2005 Jun 1;79(3):231-41 - PubMed
  3. Photochem Photobiol. 2005 Jan-Feb;81(1):96-105 - PubMed
  4. Med Phys. 1992 Jul-Aug;19(4):879-88 - PubMed
  5. Clin Cancer Res. 2001 Mar;7(3):651-60 - PubMed
  6. Appl Opt. 2001 Sep 1;40(25):4633-46 - PubMed
  7. Photochem Photobiol. 1987 Jul;46(1):97-101 - PubMed
  8. Appl Opt. 1994 Jan 20;33(3):414-23 - PubMed
  9. Photochem Photobiol. 1998 Jun;67(6):612-25 - PubMed
  10. Photochem Photobiol. 1996 Jun;63(6):892-7 - PubMed
  11. Appl Opt. 2005 Apr 1;44(10):1917-33 - PubMed
  12. Proc SPIE Int Soc Opt Eng. 2014 Jun 14;5315:132-142 - PubMed
  13. Photochem Photobiol. 2001 Jan;73(1):54-63 - PubMed
  14. Lasers Med Sci. 1997 Oct;12(3):182-99 - PubMed
  15. Appl Opt. 1996 Apr 1;35(10):1780-92 - PubMed
  16. Appl Opt. 2001 Dec 1;40(34):6389-95 - PubMed
  17. Appl Opt. 1997 Sep 1;36(25):6513-9 - PubMed
  18. Appl Opt. 2003 May 1;42(13):2436-42 - PubMed
  19. J Biomed Opt. 1998 Apr;3(2):171-86 - PubMed

Publication Types

Grant support